Page 289 - metagenics-catalogue_c_en_5

UltraInflamX Mango

Product description

Delicious, hypo-allergenic, high-quality, vegetarian powder based on rice
protein enriched with nutrients which support the formation of beneficial
prostaglandins (short-living, physiologically very active substances which
optimally regulate all kinds of body functions, i.e. cholesterol level,
liver, lung, joint and skin function, resistance.).
Supports the cleansing function of the liver.
Contains antioxidants for healthy respiratory passages and intestines, smooth
joints, a clean skin.
Free of milk products, gluten, wheat, corn, yeast, soy, egg nor artificial
colorings or flavorings.

Ingredients

NUTRITIONAL INFORMATION PER 52 g
% RDA*
kJ 774.00
kcal 183.00
Protein 12.70 g
Carbohydrate 26.10 g
Lipids 4.00 g
Fiber 1.80 g

Vit. A 1200.00 µg 150%
- retinyl palmitate 720.00 µg
- beta-caroten 480.00 µg **RE
Vit. B1 (thiamine HCl) 2.00 mg 182%
Vit. B2 (riboflavin) 1.40 mg 100%
Vit. B3 (niacinamid, niacin) 35.00 mg 219%
Vit. B6 (pyridoxine HCl) 2.80 mg 200%
Vit. B12 (cyanocobalamin) 2.50 µg 100%
Vit. C (ascorbin acid) 160.00 mg 200%
Vit. D (cholecalcipherol) 2.50 µg 50%
Vit. E (D-alpha tocopherol acetate) 30.00 mg 250%

Pantothenic acid 6.00 mg 100%
Biotin 150.00 µg 300%
Folic acid 150.00 µg 75%
Calcium (citrate) 250.00 mg 31%

Metagenics Europe | info@metagenics.eu | +32(0)59/80.58.24 | www.metagenics.eu Drawn Up 15/12/2012 UltraInflamX Mango 3637
The information given in this publication is intended explicitly for readers who deal with health and nutrition on professional grounds. In the interest of public health this publication is not intended
for lay people or consumers. Publisher and authors declare that this publication has been compiled meticulously and to the best of their knowledge. However, they cannot be held responsible for
the comprehensiveness or potential mistakes of this publication. Publisher and authors do not accept any responsibility for damage, of any kind, resulting from actions and/or decisions based on the
contents of this publication.